SOPHiA GENETICS SASOPH

Key ratios

FCF / Sales

-47.2%2025

2024 -68.7%2023 -87.7%

Net margin

-93.9%TTM

2025 -102.2%2024 -95.9%2023 -126.6%

ROA

-24.5%TTM

2025 -27.9%2024 -23.0%2023 -20.8%

ROE

-101.2%TTM

2025 -110.0%2024 -50.4%2023 -44.9%

Revenue growth

18.6%2025

2024 4.5%2023 31.1%

Recent news

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies 2026-08-04 · Newswire (CNW)

Track SOPH in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer